Expand PTGX Menu
PTGX MENU

PTGX Latest Press Releases

-- January 7, 2026 --

Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026 ACCESS Newswire 7:30 AM

-- January 5, 2026 --

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV) Business Wire 7:00 AM

-- December 6, 2025 --

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera Business Wire 9:30 AM

-- November 27, 2025 --

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice ACCESS Newswire 3:45 AM

-- November 6, 2025 --

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update ACCESS Newswire 4:05 PM

-- November 3, 2025 --

Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting ACCESS Newswire 4:05 PM

-- October 27, 2025 --

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences ACCESS Newswire 7:35 AM

-- October 21, 2025 --

Big Pharma Just Put Peptides Back on the Map - Which Players Are Still Under the Radar? AB Digital Inc 3:34 PM

-- October 7, 2025 --

Protagonist Announces New Icotrokinra Data in Ulcerative Colitis Showing Potential for a Standout Combination of Therapeutic Benefit and a Favorable Safety Profile in Once-daily Pill ACCESS Newswire 8:10 AM

-- September 17, 2025 --

Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the EADV 2025 Congress ACCESS Newswire 8:00 AM

-- September 15, 2025 --

Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berlin 2025 ACCESS Newswire 10:45 AM

-- September 11, 2025 --

Protagonist Announces Icotrokinra Application for Approval in Plaque Psoriasis Submitted to the European Medicines Agency ACCESS Newswire 8:00 AM
Market Data Delayed 15 Minutes